These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 37609317)

  • 41. Establishing disease causality for a novel gene variant in familial dilated cardiomyopathy using a functional in-vitro assay of regulated thin filaments and human cardiac myosin.
    Pan S; Sommese RF; Sallam KI; Nag S; Sutton S; Miller SM; Spudich JA; Ruppel KM; Ashley EA
    BMC Med Genet; 2015 Oct; 16():97. PubMed ID: 26498512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro analyses of suspected arrhythmogenic thin filament variants as a cause of sudden cardiac death in infants.
    Shafaattalab S; Li AY; Lin E; Stevens CM; Dewar LJ; Lynn FC; Sanatani S; Laksman Z; Morin RD; van Petegem F; Hove-Madsen L; Tieleman DP; Davis JP; Tibbits GF
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):6969-6974. PubMed ID: 30886088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy.
    Fujita E; Nakanishi T; Nishizawa T; Hagiwara N; Matsuoka R
    Heart Vessels; 2013 Nov; 28(6):785-94. PubMed ID: 23494605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca
    Robinson P; Sparrow AJ; Patel S; Malinowska M; Reilly SN; Zhang YH; Casadei B; Watkins H; Redwood C
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H306-H319. PubMed ID: 32618513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy.
    Forissier JF; Carrier L; Farza H; Bonne G; Bercovici J; Richard P; Hainque B; Townsend PJ; Yacoub MH; Fauré S; Dubourg O; Millaire A; Hagège AA; Desnos M; Komajda M; Schwartz K
    Circulation; 1996 Dec; 94(12):3069-73. PubMed ID: 8989109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rat cardiac troponin T mutation (F72L)-mediated impact on thin filament cooperativity is divergently modulated by α- and β-myosin heavy chain isoforms.
    Chandra V; Gollapudi SK; Chandra M
    Am J Physiol Heart Circ Physiol; 2015 Oct; 309(8):H1260-70. PubMed ID: 26342069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measurement of Myofilament-Localized Calcium Dynamics in Adult Cardiomyocytes and the Effect of Hypertrophic Cardiomyopathy Mutations.
    Sparrow AJ; Sievert K; Patel S; Chang YF; Broyles CN; Brook FA; Watkins H; Geeves MA; Redwood CS; Robinson P; Daniels MJ
    Circ Res; 2019 Apr; 124(8):1228-1239. PubMed ID: 30732532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy-Associated Mutation in Human Cardiac Troponin I (K206I).
    Warren CM; Karam CN; Wolska BM; Kobayashi T; de Tombe PP; Arteaga GM; Bos JM; Ackerman MJ; Solaro RJ
    Circ Cardiovasc Genet; 2015 Dec; 8(6):765-73. PubMed ID: 26553696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptomic Analysis of Cardiomyocyte Extracellular Vesicles in Hypertrophic Cardiomyopathy Reveals Differential snoRNA Cargo.
    James V; Nizamudeen ZA; Lea D; Dottorini T; Holmes TL; Johnson BB; Arkill KP; Denning C; Smith JGW
    Stem Cells Dev; 2021 Dec; 30(24):1215-1227. PubMed ID: 34806414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy.
    Crocini C; Ferrantini C; Scardigli M; Coppini R; Mazzoni L; Lazzeri E; Pioner JM; Scellini B; Guo A; Song LS; Yan P; Loew LM; Tardiff J; Tesi C; Vanzi F; Cerbai E; Pavone FS; Sacconi L; Poggesi C
    J Mol Cell Cardiol; 2016 Feb; 91():42-51. PubMed ID: 26714042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MYBPH acts as modifier of cardiac hypertrophy in hypertrophic cardiomyopathy (HCM) patients.
    Mouton JM; van der Merwe L; Goosen A; Revera M; Brink PA; Moolman-Smook JC; Kinnear C
    Hum Genet; 2016 May; 135(5):477-483. PubMed ID: 26969327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia.
    Schober T; Huke S; Venkataraman R; Gryshchenko O; Kryshtal D; Hwang HS; Baudenbacher FJ; Knollmann BC
    Circ Res; 2012 Jul; 111(2):170-9. PubMed ID: 22647877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The TNNT2:c.95-108G>A variant is common in Maine Coons and shows no association with hypertrophic cardiomyopathy.
    Schipper T; Ohlsson Å; Longeri M; Hayward JJ; Mouttham L; Ferrari P; Smets P; Ljungvall I; Häggström J; Stern JA; Lyons LA; Peelman LJ; Broeckx BJG
    Anim Genet; 2022 Aug; 53(4):526-529. PubMed ID: 35634705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel Genetic Variants in BAG3 and TNNT2 in a Swedish Family with a History of Dilated Cardiomyopathy and Sudden Cardiac Death.
    Fernlund E; Österberg AW; Kuchinskaya E; Gustafsson M; Jansson K; Gunnarsson C
    Pediatr Cardiol; 2017 Aug; 38(6):1262-1268. PubMed ID: 28669108
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.
    Prondzynski M; Lemoine MD; Zech AT; Horváth A; Di Mauro V; Koivumäki JT; Kresin N; Busch J; Krause T; Krämer E; Schlossarek S; Spohn M; Friedrich FW; Münch J; Laufer SD; Redwood C; Volk AE; Hansen A; Mearini G; Catalucci D; Meyer C; Christ T; Patten M; Eschenhagen T; Carrier L
    EMBO Mol Med; 2019 Dec; 11(12):e11115. PubMed ID: 31680489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation.
    Parvatiyar MS; Landstrom AP; Figueiredo-Freitas C; Potter JD; Ackerman MJ; Pinto JR
    J Biol Chem; 2012 Sep; 287(38):31845-55. PubMed ID: 22815480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.
    Tanaka A; Yuasa S; Mearini G; Egashira T; Seki T; Kodaira M; Kusumoto D; Kuroda Y; Okata S; Suzuki T; Inohara T; Arimura T; Makino S; Kimura K; Kimura A; Furukawa T; Carrier L; Node K; Fukuda K
    J Am Heart Assoc; 2014 Nov; 3(6):e001263. PubMed ID: 25389285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes.
    Ramachandra CJA; Kp MMJ; Chua J; Hernandez-Resendiz S; Liehn EA; Knöll R; Gan LM; Michaëlsson E; Jonsson MKB; Ryden-Markinhuhta K; Bhat RV; Fritsche-Danielson R; Lin YH; Sadayappan S; Tang HC; Wong P; Shim W; Hausenloy DJ
    Cardiovasc Res; 2022 Jan; 118(2):517-530. PubMed ID: 33705529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiac Troponin T (TNNT2) mutations are less prevalent in Indian hypertrophic cardiomyopathy patients.
    Rani DS; Nallari P; Dhandapany PS; Tamilarasi S; Shah A; Archana V; AshokKumar M; Narasimhan C; Singh L; Thangaraj K
    DNA Cell Biol; 2012 Apr; 31(4):616-24. PubMed ID: 22017532
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural and functional impact of troponin C-mediated Ca
    Gonzalez-Martinez D; Johnston JR; Landim-Vieira M; Ma W; Antipova O; Awan O; Irving TC; Bryant Chase P; Pinto JR
    J Mol Cell Cardiol; 2018 Oct; 123():26-37. PubMed ID: 30138628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.